HCPCS Level II code L8687 represents an implantable, rechargeable neurostimulator pulse generator configured for dual-array leads and supplied with an extension. Implantable neurostimulators are used in neuromodulation therapies for chronic pain, movement disorders, and other refractory neurologic conditions; a specific device-level code such as L8687 matters nationally because it affects billing, device tracking, and payment across hospital and ambulatory surgical settings. Key payers in the national landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. This publication provides clinicians, billing professionals, and policy analysts with benchmarks and context for L8687, including the clinical service type (implantable neurostimulation device provision/implantation), typical sites of service (inpatient hospitals and outpatient surgical centers), and payer coverage considerations. Readers will learn the basic device description and clinical setting, common procedural contexts where the device is billed, and where to find related coding and policy references. Data not available in the input for specific payer reimbursement rates, associated taxonomies, ICD-10 diagnosis mappings, and related codes are noted where relevant.